All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.

D. Hughes; D.A. Hughes; [No Value] All Wales Strategy Group.

All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.

D. Hughes
, D.A. Hughes
, [No Value] All Wales Strategy Group.

NHS Wales

Research output: Book/Report › Commissioned report

Original language	English
Publisher	Unknown
Commissioning body	NHS Wales
Edition	2009
Publication status	Published - 1 Jan 2009

Cite this

Hughes, D., Hughes, D. A., & All Wales Strategy Group., N. V. (2009). All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients. (2009 ed.) Unknown.

Hughes, D. ; Hughes, D.A. ; All Wales Strategy Group., [No Value]. / All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients. 2009 ed. Unknown, 2009.

@book{f2032ba644e047d1a08adcdf5bac8425,

title = "All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.",

author = "D. Hughes and D.A. Hughes and \{All Wales Strategy Group.\}, \{[No Value]\}",

year = "2009",

month = jan,

day = "1",

language = "English",

publisher = "Unknown",

edition = "2009",

}

Hughes, D, Hughes, DA & All Wales Strategy Group., NV 2009, All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients. 2009 edn, Unknown.

All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients. / Hughes, D.; Hughes, D.A.; All Wales Strategy Group., [No Value].
2009 ed. Unknown, 2009.

Research output: Book/Report › Commissioned report

TY - BOOK

T1 - All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.

AU - Hughes, D.

AU - Hughes, D.A.

AU - All Wales Strategy Group., [No Value]

PY - 2009/1/1

Y1 - 2009/1/1

UR - http://www.wales.nhs.uk/sites3/Documents/371/Tacrolimus%20_advagraf_%20FAR.pdf

M3 - Commissioned report

BT - All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.

PB - Unknown

ER -

Hughes D, Hughes DA, All Wales Strategy Group. NV. All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients. 2009 ed. Unknown, 2009.

Other files and links

Cite this